Journal
CELLULAR IMMUNOLOGY
Volume 311, Issue -, Pages 1-12Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2016.09.012
Keywords
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs); Experimental autoimmune; encephalomyelitis (EAE); Immunomodulatory properties; IFN-gamma; Cell therapy
Categories
Ask authors/readers for more resources
Interferon gamma (IFN-gamma) increases the immunosuppressive property of human Wharton's jelly mesenchymal stem cells (hWJ-MSCs). In this study, we evaluated the therapeutic effects of IFN-gamma primed WJ-MSCs in EAE mice. IFN-gamma primed WJ-MSCs were injected on days 3 and 11 after EAE induction. 21 days after EAE induction, splenocytes and cervical lymph node cells were isolated and cell proliferation, secretion of inflammatory cytokines and frequency of regulatory T-cells was measured. On day 50 of the study, cell infiltration and gene expression of inflammatory cytokines in brain of mice were studied. Leukocyte infiltration and symptoms were significantly reduced in IFN-gamma primed WJ-MSCs treated group compared to other groups. These cells showed significantly reduced proliferation and increased Treg cells as well as decreased secretion and gene expression of inflammatory cytokines in EAE mice. Our data suggest that IFN-gamma may be used to stimulate the immunomodulatory property of WJ-MSCs in clinical situations. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available